Simhanada Guggulu
Simhanada Guggulu is a classical Ayurvedic guggulu, a resin-based preparation. Listed in Ayurvedic Formulary of India (AFI) Part I; described in Ayurvedic Pharmacopoeia of India (API); included in CCRAS clinical practice guidelines for Amavata (Rheumatoid Arthritis).
| Also known as | Simhanada Guggulu, SimhanadaGuggulu |
|---|---|
| Pharmacopoeia status | Listed in Ayurvedic Formulary of India (AFI) Part I; described in Ayurvedic Pharmacopoeia of India (API); included in CCRAS clinical practice guidelines for Amavata (Rheumatoid Arthritis) |
Names and identification
| Language | Name |
|---|---|
| English | Simhanada Guggulu |
Where is it described in the classical texts?
Bhaishajya Ratnavali (Amavata Chikitsa Prakarana, Chapter 29); also described in Chakradatta (Amavata Chikitsa) and Yoga Ratnakara
How does it work?
- DMARD-like action: The combined ingredients function as Disease Modifying Anti-Rheumatic Drugs, modulating immune response and preventing progressive joint destruction in rheumatoid arthritis
- Ama Pachana (toxin digestion): Shuddha Gandhaka (purified sulphur) and castor oil act synergistically to digest metabolic toxins (Ama) that are considered the root cause of Amavata in Ayurvedic pathology
- Anti-inflammatory and anti-gout: Triphala provides potent antioxidant, anti-inflammatory, and anti-hyperuricemic effects; guggulsterones inhibit pro-inflammatory cytokine cascades
- Mild purgative detoxification: Castor oil (Eranda Taila) provides gentle laxative effect that eliminates accumulated Ama from the GI tract, breaking the Ama-Vata cycle
- Immunomodulation: Guduchi (Tinospora cordifolia) modulates both innate and adaptive immune responses, reducing autoimmune-mediated joint destruction
Which traditional uses are supported by research?
- Rheumatoid arthritis (Amavata) management validated through multiple reviews confirming DMARD-like activity with significant reduction in inflammation, pain, and stiffness
- Anti-gout and anti-hyperuricemic activity validated through Triphala’s demonstrated anti-hyperuricemic effects in pharmacological studies
- Joint flexibility improvement validated through clinical observations showing enhanced mobility and reduced swelling
- Detoxification and Ama elimination validated through the laxative and digestive mechanisms of castor oil and purified sulphur combination
What do recent clinical trials show?
3 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.
Recent safety updates
- Contains purified sulphur which may cause mild GI discomfort in some patients; castor oil component may cause loose stools; avoid in patients with diarrhea or irritable bowel syndrome; not recommended during pregnancy and lactation
- Long-term use should be monitored; guggulu may interact with anticoagulant drugs; avoid in patients with bleeding disorders; discontinue if skin rash or allergic reaction occurs
What is it made of?
Mineral/Elemental Profile
- Primary component: Mineral-derived preparation
- Note: Composition varies by specific preparation method
Analytical Methods: XRD, ICP-OES, SEM-EDS
Dosage forms and preparation
Dosage Forms: Vati (pill/tablet), Capsule
Standard Dosage: 2 tablets at bedtime
Bioavailability: Guggulu resin acts as natural bioenhancer; guggulsterones have moderate oral bioavailability (~40%); lipophilic matrix aids absorption of co-formulated herbs
Optimal Timing: After meals, twice daily
Shelf Life: 2 years (guggulu preparations per ASU); potency may decrease after 1 year
Storage: Airtight container, cool dry place; guggulu preparations are hygroscopic
Marker Compounds: Guggulsterone, Gallic acid, Sulfur
Quality Parameters: Weight variation ±5%, disintegration <60 min, hardness 4-8 kP, assay: Guggulsterone, Gallic acid, Sulfur, guggulsterone content
Vehicle (Anupana): Warm water
Synergistic Combinations
- Key herbs: Guggulu, Triphala, Gandhaka, Eranda taila; guggulu potentiates anti-inflammatory and hypolipidemic actions
Composition
As given in the Ayurvedic Formulary of India, Part I, entry 5:12 (SIMHANADA GUGGULU), which cites Bhaisajyaratnavali, Amavatadhikara; 130-131.. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.
| # | Ingredient | Part | Quantity |
|---|---|---|---|
| 1 | Haritaki | pericarp | 48 g. |
| 2 | Bibhitaka | pericarp | 48 g. |
| 3 | Amalaki | pericarp | 48 g. |
| 4 | Water for decoction | 576 ml. reduced to 144 ml. | |
| 5 | Saugandhika (gandhaka)-suddha (gandhaka) | 48 g. | |
| 6 | Kausika (guggulu)-suddha (guggulu) | exudate | 48 g. |
| 7 | Citra taila (eranda) (eranda) | oil | 192 g. |
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.